Aelian Biotechnology Competitors and Similar CompaniesClear all
Bluebird Bio's competitors and similar companies include Algenex, ZoBio and Wings Therapeutics.
 Algenex Algenex is a biotechnology company developing technologies to support the production of recombinant proteins using Baculovirus vector expression systems (BVES) in insect cells. |  ZoBio ZoBio is a company that provides gene to structure research services in early stage drug discovery. |  Wings Therapeutics Wings Therapeutics is a biotechnology company engaged in the development of therapies for patients suffering from Dystrophic Epidermolysis Bullosa (DEB), a rare genetic skin blistering disease. | ||
Founding Date | Founding Date 1992 | Founding Date 2005 | Founding Date 2004 | Founding Date 2019 |
Type | Type Public | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Somerville, US HQ | Locations Madrid, ES HQ | Locations Leiden, NL HQ | Locations Berkeley, US HQ |
Employees | Employees 32338% decrease | Employees 403% increase | Employees 432% decrease | Employees 5 |
Funding | ||||
Total funding raised | Total funding raised $ 409m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 1.5m |
For sources of this data, please see the company profile
View Company Profiles
Algenex
HQ
Madrid, ES
Employees
40↑ 3% increase
Algenex is a biotechnology company developing technologies to support the production of recombinant proteins using Baculovirus vector expression systems (BVES) in insect cells.
View companyZoBio
HQ
Leiden, NL
Employees
43↓ 2% decrease
ZoBio is a company that provides gene to structure research services in early stage drug discovery.
View companyWings Therapeutics
HQ
Berkeley, US
Employees
5
Wings Therapeutics is a biotechnology company engaged in the development of therapies for patients suffering from Dystrophic Epidermolysis Bullosa (DEB), a rare genetic skin blistering disease.
View company